STAT3 and gastric carcinoma: This is attained byinhibiting the process of STAT3 translocation, access to nucleus and combination with VEGF promoter in gastric carcinoma [190,191], as well as the inhibition of VEGF protein level, secretion, and mRNA expression due to reduced activation of STAT3 in gastric carcinoma [192].